Rapid Pathogen Screening Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Rapid Pathogen Screening Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010965
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Rapid Pathogen Screening Inc (Rapid Pathogen) is a biotechnology company that designs, develops, manufactures and markets point-of-care diagnostic tests. The company uses its patented direct sampling micro-filtration and direct multi-planar chromafiltography technology to develop various tests. Its product portfolio includes AdenoPlus, a CLIA-waived, point-of-care test that identifies serotypes of adenoviral conjunctivitis; and the InflammaDry test for dry eye. Rapid Pathogen’s FebriDx test helps to identify pathogen induced immune response to viral and bacterial acute febrile respiratory infection. The company develops solutions for infectious diseases and inflammatory conditions. It also offers bio-terrorism and chemical nerve agent blood toxin solutions. Rapid Pathogen is headquartered in Sarasota, Florida, the US.

Rapid Pathogen Screening Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Rapid Pathogen Screening Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Rapid Pathogen Screening Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Rapid Pathogen Screening Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Rapid Pathogen Screening Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Rapid Pathogen Screening Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Rapid Pathogen Screening Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Rapid Pathogen Screening Raises USD28 Million in Venture Debt Financing 10
Rapid Pathogen Screening Raises US$2.3 Million In Venture Financing 11
Rapid Pathogen Screening Raises US$6.2 Million In Venture Financing 12
Rapid Pathogen Screening Raises Additional US$2 Million In Venture Financing 13
Rapid Pathogen Screening Raises US$5.2 Million In Venture Financing 14
Partnerships 15
FSC Labs Enters into Licensing Agreement with Rapid Pathogen Screening 15
NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus 16
NicOx Amends Licensing Agreement with Rapid Pathogen Screening for AdenoPlus 17
Asset Transactions 18
Quidel Acquires InflammaDry and AdenoPlus Diagnostic Businesses from Rapid Pathogen Screening for USD14 Million 18
Rapid Pathogen Screening Inc – Key Competitors 19
Rapid Pathogen Screening Inc – Key Employees 20
Rapid Pathogen Screening Inc – Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Rapid Pathogen Screening Inc, Medical Equipment, Key Facts 2
Rapid Pathogen Screening Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Rapid Pathogen Screening Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Rapid Pathogen Screening Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Rapid Pathogen Screening Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Rapid Pathogen Screening Inc, Deals By Market, 2011 to YTD 2017 8
Rapid Pathogen Screening Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Rapid Pathogen Screening Raises USD28 Million in Venture Debt Financing 10
Rapid Pathogen Screening Raises US$2.3 Million In Venture Financing 11
Rapid Pathogen Screening Raises US$6.2 Million In Venture Financing 12
Rapid Pathogen Screening Raises Additional US$2 Million In Venture Financing 13
Rapid Pathogen Screening Raises US$5.2 Million In Venture Financing 14
FSC Labs Enters into Licensing Agreement with Rapid Pathogen Screening 15
NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus 16
NicOx Amends Licensing Agreement with Rapid Pathogen Screening for AdenoPlus 17
Quidel Acquires InflammaDry and AdenoPlus Diagnostic Businesses from Rapid Pathogen Screening for USD14 Million 18
Rapid Pathogen Screening Inc, Key Competitors 19
Rapid Pathogen Screening Inc, Key Employees 20

★海外企業調査レポート[Rapid Pathogen Screening Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Export Development Bank Of Egypt:企業の戦略・SWOT・財務情報
    Export Development Bank Of Egypt - Strategy, SWOT and Corporate Finance Report Summary Export Development Bank Of Egypt - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Chr. Hansen Holding AS (CHR):製薬・医療:M&Aディール及び事業提携情報
    Summary Chr. Hansen Holding A/S (Chr. Hansen) is a bioscience company that focuses on the development of natural ingredient solutions for the food, pharmaceutical, nutritional and agricultural industries. The company develops, produces and markets cultures, enzymes, probiotics and natural colors. It …
  • Flanders Institute for Biotechnology:製薬・医療:M&Aディール及び事業提携情報
    Summary Flanders Institute for Biotechnology (VIB) is a non-profit life sciences research institute that offers pharmaceutical, agricultural, and other industrial research programs. The institute offers research services in areas of cardiovascular medicine, bioinformatics, proteomics and systems bio …
  • Apex Oil Company, Inc.:企業の戦略・SWOT・財務分析
    Apex Oil Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Apex Oil Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Covanta Holding Corp (CVA):企業の財務・戦略的SWOT分析
    Covanta Holding Corp (CVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Shearman & Sterling LLP:企業の戦略的SWOT分析
    Shearman & Sterling LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • QT Vascular Ltd (5I0):医療機器:M&Aディール及び事業提携情報
    Summary QT Vascular Ltd (QT Vascular) is a medical device manufacturing company that offers developing, manufacturing and distributing of advanced therapeutic solutions for the treatment of complex vascular diseases. The company’s products include coronary products such as Chocolate PTCA Balloon Cat …
  • Celulosa Arauco y Constitucion SA:企業の戦略的SWOT分析
    Celulosa Arauco y Constitucion SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Gujarat Industries Power Co Ltd (GIPCL):企業の財務・戦略的SWOT分析
    Gujarat Industries Power Co Ltd (GIPCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Sihayo Gold Ltd:企業の戦略・SWOT・財務分析
    Sihayo Gold Ltd - Strategy, SWOT and Corporate Finance Report Summary Sihayo Gold Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Umicore SA:企業の戦略・SWOT・財務情報
    Umicore SA - Strategy, SWOT and Corporate Finance Report Summary Umicore SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Ryerson Holding Corp:企業の戦略・SWOT・財務情報
    Ryerson Holding Corp - Strategy, SWOT and Corporate Finance Report Summary Ryerson Holding Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Johnson Matthey Plc (JMAT):企業の財務・戦略的SWOT分析
    Johnson Matthey Plc (JMAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Aavin Equity Advisors, LLC:企業の戦略・SWOT・財務分析
    Aavin Equity Advisors, LLC - Strategy, SWOT and Corporate Finance Report Summary Aavin Equity Advisors, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Synthetic Biologics Inc (SYN):製薬・医療:M&Aディール及び事業提携情報
    Summary Synthetic Biologics Inc (Synthetic Biologics), formerly Adeona Pharmaceuticals Inc is a clinical company that develops novel therapeutics to treat gut microbiome. The company’s pipeline products include SYN-004 and SYN-010. Its SYN-010 is a proprietary, modified-release formulation which is …
  • New York Independent System Operator Inc:企業の戦略的SWOT分析
    New York Independent System Operator Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • NeoGenomics Inc (NEO):企業の財務・戦略的SWOT分析
    Summary NeoGenomics Inc (NeoGenomics) is a cancer diagnostics and pharma services company that offers diagnostic, prognostic and predictive testing services. The company offers testing services with various technologies such as cytogenetics, fluorescence in-situ hybridization, flow cytometry, immuno …
  • Pyxus International Inc:企業の戦略・SWOT・財務情報
    Pyxus International Inc - Strategy, SWOT and Corporate Finance Report Summary Pyxus International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • MADO Ice Cream & Foodstuffs Co., Ltd.:企業の戦略・SWOT・財務分析
    MADO Ice Cream & Foodstuffs Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary MADO Ice Cream & Foodstuffs Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Lincoln Pharmaceuticals Ltd (LINCOLN):企業の財務・戦略的SWOT分析
    Lincoln Pharmaceuticals Ltd (LINCOLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆